22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia ... 1, 2023 — New research has ...

The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

Fast Track designation has the goal of bringing new treatments to patients sooner. In granting Fast Track, the FDA recognized fibromyalgia as a "serious condition," which shows the recognition ...

Branded Drugs: Branded pharmaceutical treatments are often used when they offer higher efficacy and better management of fibromyalgia symptoms. These companies are focusing on expanding their product ...

Fibromyalgia, the chronic pain condition that plagues approximately ten million Americans is in need of new drug treatment options. The existing approved drugs on the market often aren't enough.

He highlighted the fibromyalgia community's long wait for a new therapeutic option and noted that current treatments often lead to the prescription of addictive opioids. The company is preparing ...

Growing awareness about fibromyalgia and advancements in treatment options drive market growth. Generic Medication Accessibility: Enhanced availability of generic medications for fibromyalgia ...